VivaDiag SARS-CoV-2 Ag Fast Check tugineb immuunanalüüsi oskusteabele SARS-CoV-2 nukleokapsiidi valgu antigeeni kiireks ja kvalitatiivseks tuvastamiseks inimese orofarünksi või ninaneelu tampooniproovides. Kontroll annab lõpptulemuse 15 minuti jooksul, selgitades välja COVID-19-ga saastunud isikud, kes aitavad kiiresti kaasa viiruse levikule.
Pakett sisaldab kõiki vajalikke vidinaid koos tampooni, väljatõmbetoru, ekstraheerimise eraldusvõime ja külgmise ringluse kontrollsüsteemiga. Selle kontrolli kasutamiseks ei ole vaja spetsiaalset varustust ega personali. Hinnanguid võivad läbi viia haritud töötajad igal ajal ja igal ajal, st ainult kvalifitseeritud kasutamiseks
See külgvereringe Covid-19 kiire antigeeni kontrollimise seade on haritud personalil hõlpsasti õigete tulemuste saavutamiseks, kasutades kiiresti neelu- või ninaneelu tampooniproovi.
Kui proov on kogutud, sisestage tampoon ekstraheerimise eraldusvõimega täidetud ekstraheerimistorusse. Pärast suletud pakendist testimissüsteemi eemaldamist lisage kolm tilka vastust ja oodake 15 minutit varem kui tšeki uurimine, mis näitab selgelt optimistlikku või kahjulikku tulemust.
Selle Covid-19 kiire antigeenikontrolli seadme üldine täpsus on 98,79%, spetsiifilisus 99,12% ja tundlikkus 90,90%, mis tagab täieliku kindluse kiirete, õigete ja usaldusväärsete tulemuste kohta.
Neid hinnanguid tuleb kasutada osana täielikult sisseehitatud COVID-19 tehnikast, mille abil määratakse need saastunud, et vähendada viiruse levikut. VivaDiag ™ SARS-CoV-2 Ag Fast Check on loodud AINULT täiendava kontrollina, kui kahtlustatakse koronaviiruse kahjuliku nukleiinhappe avastamist, või koos nukleiinhappe tuvastamisega kahtlustatavate juhtumite analüüsimisel. Nukleokapsiidi valgu antigeeni testimise tulemusi ei tohiks kasutada ainsa tõelise alusena SARS-CoV-2 (COVID-19) nakkuse diagnoosimiseks või välistamiseks või nakkuse seismiseks.
Ettekirjutus ja mõeldud kasutamine
Immupass VivaDiag SARS-CoV-2 Ag Fast Check on mõeldud meditsiinilaboritele ja kvalifitseeritud tervishoiutöötajatele ainult hoolduspunktide testimiseks. Mitte koduseks testimiseks.
Immupass VivaDiag ™ SARS-CoV-2 Ag Fast Check tugineb immuunanalüüsi oskusteabele. Igas kontrollisüsteemis on tuvastusliinil (T-joon) üks rida SARS-vastaseid koronaviiruse monoklonaalseid antikehi ja üks rida hiirevastaseid IgG-polüklonaalseid antikehi standardsel juhtimisliinil (C-joon).
Kui ekstraheeritud proov on proovile korralikult lisatud, peaks see reageerima märgistatud antikehaga, et sisestada peen, kombinatsioon migreerub seejärel membraani kaudu kapillaarliigutusega ja interakteerub kaetud SARS-vastase koronaviiruse monoklonaalse antikehaga. Kui proov sisaldab SARS-CoV-2 antigeeni, tundub tuvastusjoon lillakaspunane, mis näitab, et SARS-CoV-2 antigeen on optimistlik . Igal muul juhul on kontrolli lõpptulemus kahjulik . Kontrollisüsteem sisaldab lisaks tippkvaliteediga juhtimisliini C, mis peaks kõigi õigustatud hinnangute puhul tunduma lillakaspunane. Kui tavaline haldusliin C ei tundu, on kontrolli lõpptulemus kehtetu isegi siis, kui tuvastusjoon tundub.
Koostis
Iga tšekipakett sisaldab: 25 tšekividinat, 25 väljatõmbetoru (eeltäidetud ekstraheerimise eraldusvõimega 300 μL / tuub), filtreeritud düüse, 1 tuubialust, 25 steriilset tampooni ja 1 kimp.
Vajalikke tarvikuid ei saanud siiski tarnida: taimer.
SARS-CoV-2 Rapid Antigen Test Nasal |
|||
| 9901-NCOV-03G | Roche Diagnostics | 25 Tests/Kit | EUR 112.8 |
|
Description: The SARS-CoV-2 Rapid Antigen Test is a lateral fl ow rapid chromatographic immunoassay for the qualitative detection of nucleocapsid antigen to SARS-CoV-2 present in human nasal samples. This test is intended for use as an aid in detection of SARS-CoV-2 infection in individuals suspected of COVID-19 with clinical symptoms onset within 5 days. Results are for the identification of SARS-CoV-2 nucleocapsid antigen. Antigen is generally detectable in human nasal swab samples during the acute phase of infection. Positive results indicate the presence of viral antigens, but clinical correlation with patient history and other diagnostic information is necessary to determine infection status. Positive results do not rule out bacterial infection or co- infection with other viruses. The agent detected may not be the definite cause of disease. Negative results should be treated as presumptive, and do not rule out SARS-CoV-2 infection and should not be used as the sole basis for treatment or patient management decisions, including infection control decisions. Negative results should be considered in the context of a patient’s recent exposures, history and the presence of clinical signs and symptoms consistent with COVID-19, and confirmed with a molecular assay, if necessary, for patient management. The SARS-CoV-2 Rapid Antigen Test is intended for use in laboratory or POC settings by healthcare professionals, or self-collection under the supervision of a healthcare worke |
|||
Coronavirus (SARS-Cov-2) Antigen Rapid Test Device (Saliva) |
|||
| IOV87952 | INVBIO | 20T/kit | EUR 46.8 |
|
Description: Coronavirus (SARS-Cov-2) Antigen Rapid Test Device (Saliva) is an in vitro diagnostic test for the qualitative detection of novel coronavirus antigens in human saliva, using the rapid immunochromatographic method. The identification is based on the monoclonal antibodies specific for the novel coronvirus antigen. It will provide information for clinical doctors to prescribe correct medications. |
|||
Accu-Tell COVID-19 IgG/IgM Rapid Test |
|||
| GEN-B352-20tests | Accu test | 20 tests | EUR 283.2 |
|
Description: A rapid test for detection of antibodies (IgG and IgM) for 2019-nCoV, the novel Coronavirus from the Wuhan strain. The test is easy to perform, takes 10 minutes to provide reliable results and is higly specific to the 2019-nCoV Coronavirus. |
|||
Accu-Tell COVID-19 IgG/IgM Rapid Test |
|||
| GEN-B352-40tests | Accu test | 40 tests | EUR 385.2 |
|
Description: A rapid test for detection of antibodies (IgG and IgM) for 2019-nCoV, the novel Coronavirus from the Wuhan strain. The test is easy to perform, takes 10 minutes to provide reliable results and is higly specific to the 2019-nCoV Coronavirus. |
|||
Panbio™ COVID-19 Ag Rapid Test Device |
|||
| 41FK10 | Abbott | 25 Tests/Kit | EUR 115.2 |
Dynamiker Monkeypox Virus Ag Rapid Test |
|||
| DNK-2114-1 | Dynamiker Biotechnology | 20 tests | EUR 702 |
|
Description: The product is a lateral flow chromatographic immunoassay for the qualitative detection of monkeypox virus antigen in human whole blood, serum, plasma or rash exuudate. The kit is intended for professional use only. |
|||
Panbio™ COVID-19 Ag Rapid Test Device (Nasal) |
|||
| 41FK11 | Abbott | 25 Tests/Kit | EUR 128 |
|
Description: The Coronavirus disease (COVID-19) is an infectious disease caused by a newly discovered coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The SARS-CoV-2 is a β -coronavirus, which is an enveloped non-segmented positive-sense RNA virus 2. It is spread by human-to-human transmission via droplets or direct contact, and infection has been estimated to have a mean incubation period of 6.4 days and a basic reproduction number of 2.24-3.58. Among patients with pneumonia caused by SARS-CoV-2, fever was the most common symptom, followed by cough3. The main IVD assays used for COVID-19 employ real-time reverse transcriptase-polymerase chain reaction (RT-PCR) that takes a few hours 4. The availability of a cost-effective, rapid point- of-care diagnostic test is critical to enable healthcare professionals to aid in the diagnosis of patients and prevent further spread of the virus5. Antigen tests will play a critical role in the fight against COVID-19 |
|||
2019-nCoV IgG/IgM Rapid Test Cassette (Whole Blood/Serum/Plasma) |
|||
| GEN-402-25tests | All test | 25 tests | EUR 292.8 |
|
Description: A rapid test for detection of antibodies (IgG and IgM) for 2019-nCoV, the novel Coronavirus from the Wuhan strain. The test is easy to perform, takes 10 minutes to provide reliable results and is higly specific to the 2019-nCoV Coronavirus. |
|||
COVID-19 IgG/IgM Rapid Test Kit |
|||
| UNCOV-20 | UnScience | 20T/kit | EUR 186 |
|
Description: COVID-19 IgG/IgM Rapid Test (Serum/Plasma/Whole Blood) is a qualitative membrane-based immunoassay for the detection of COVID-19 antibodies in serum, plasma, or whole blood. This test consists of two test lines, an IgG line and an IgM line, which is pre-coated with two mouse anti-human monoclonal antibodies separately. During testing, the sample reacts with COVID-19 antigen-coated on conjugated pad. As the complex continues to travel up the strip, the anti-COVID-19 IgM antibodies are bound on the IgM line, and the anti-COVID-19 IgG antibodies are bound on the IgG line. The control(C)line appears when sample has flowed through the strip. The presence of anti-COVID-19 IgM and/or IgG will be indicated by a visible test line in the IgM and IgG region. To serve as a procedural control, the control line should always appear if the test procedure is performed properly and the reagents are working as intended. |
|||
Melamine Rapid Test Kit |
|||
| abx092011-50tests | Abbexa | 50 tests | EUR 444 |
Panbio™ COVID-19 IgG/IgM Rapid Test |
|||
| ICO-T402 | Abbott | 25 Tests/Kit | EUR 264 |
Melamine (MEL) Rapid Test Kit |
|||
| abx092057-50tests | Abbexa | 50 tests | EUR 444 |
Quinolones (QNs) Rapid Test Kit |
|||
| abx092065-40tests | Abbexa | 40 tests | EUR 477.6 |
Salbutamol (SAL) Rapid Test Kit |
|||
| abx092060-50tests | Abbexa | 50 tests | EUR 292.8 |
Quinolones (QNs) Rapid Test Kit |
|||
| abx092067-40tests | Abbexa | 40 tests | EUR 477.6 |
Clenbuterol (CLE) Rapid Test Kit |
|||
| abx092058-50tests | Abbexa | 50 tests | EUR 292.8 |
Ractopamine (RAC) Rapid Test Kit |
|||
| abx092059-50tests | Abbexa | 50 tests | EUR 292.8 |
Tetracycline (TCs) Rapid Test Kit |
|||
| abx092063-50tests | Abbexa | 50 tests | EUR 477.6 |
Sulfonamides (Sas) Rapid Test Kit |
|||
| abx092064-40tests | Abbexa | 40 tests | EUR 477.6 |
Brucella Antibody Rapid Test Kit |
|||
| abx092069-40tests | Abbexa | 40 tests | EUR 427.2 |
Ciprofloxacin (CPFX) Rapid Test Kit |
|||
| abx092066-50tests | Abbexa | 50 tests | EUR 477.6 |
NOVATest IgG/IgM Antibody Rapid Test Kit (NOVA Test) |
|||
| UNCOV-40 | Atlas Link Technology | 40 Tests | EUR 115 |
Procalcitonin rapid test (Colloidal Gold) |
|||
| abx095264-80Units | Abbexa | 80 Units | EUR 1144.8 |
Rotavirus Rapid Test Control Pack (2 X 1.5mL) |
|||
| KZMC036 | Zeptometrix | 2 X 1.5mL | EUR 59 |
Adenovirus Rapid Test Control Pack (2 X 1.5mL) |
|||
| KZMC035 | Zeptometrix | 2 X 1.5mL | EUR 59 |